Searched for
ZYCOV D VACCINE
Vaccine will soon be available for 12-18 age group: Cadila HealthcareThe government has allowed vaccination of adolescents aged 15 to 18 years with Bharat Biotech's Covaxin, but is yet to decide on vaccinatio...
Production ramp up delayed Zydus Cadila’s vaccine launch, roll out likely soonZydus had received an order from the government to supply 10 million doses of ZyCoV-D, the world's first plasmid DNA vaccine, at ₹265 per d...
Zydus Cadila's ZyCov-D shot to soon join other vaccines in India's Covid fightThe drug regulator had on August 20 given emergency use authorisation (EUA) to the three-dose Covid-19 vaccine, the first in India that can...
NTAGI to soon come out with guidelines on vaccinating kidsZyCoV-D is the first DNA plasmid vaccine in the world , developed indigenously by the company against the Covid-19 virus.
Zydus Cadila to supply 1 crore doses of ZyCoV-D to govt at Rs 265/doseZydus Cadila will supply 1 crore doses of its vaccine ZyCoV-D, the world's first plasmid DNA vaccine to the government of India at Rs 265 p...
Zydus Cadila to get clarity on ZyCoV-D Covid vaccine pricing in 1-2 weeks: MD Sharvil PatelOn Sunday, news wire PTI reported, citing government sources, that the company had agreed to bring down the price of ZyCov-D to ₹265 a dose...
First children-friendly Covid vaccination centreFor more such web stories click on the ET icon below.
Govt finalises price of Cadila's child Covid vaccine ZyCoV-D, rollout likely soonAccording to sources, the government has negotiated the pricing of the vaccine which is "much lower than what the manufacturers had demande...
'More data needed before we can start vaccinating children'What we really need is data, based on which we can make informed decisions. All that we have at the moment is DCGI approval of the vaccines...
Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it downThe government had on Thursday said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila w...
69 pc of India's adult population has got at least one dose of Covid vaccine, 25 pc bothThe government said that 64.1 per cent doses of COVID-19 vaccine has been administered in vaccination centres in rural areas and 35 per cen...
Children with comorbidities between ages 12 and 17 may get vaccine by October-NovemberThe government is planning to get children with comorbidities the vaccine by October or November. Children between the ages of 12 and 17, w...
Government may earmark a part of Zydus vaccine for sick kidsThe drug regulator had last week approved ZyCov-D, the world’s first DNA-based vaccine against the novel coronavirus, for emergency use in ...
NTAGI to soon chalk out roadmap to introduce Zydus Cadila's vaccine in Covid inoculation driveThe indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received Emergency Use Authorisation from the drug ...
Cadila Healthcare Working on Needle-free, 2-Dose VaccineThe drug company is conducting phase-3 trials with over 20,000 participants to test whether its three-dose vaccine ZyCoV-D prevents virolog...
Covishield vaccine transport to start in less than 24 hoursKool-Ex, a Mumbai-based cold chain cargo transporter, will deploy close 150 of its reefer trucks to transport these vaccines from the manuf...
COVID-19 vaccine approval: All risks paid off, proud moment for India, say SII, Bharat BiotechPune-based vaccine major Serum Institute of India (SII) had entered into a collaboration with the University of Oxford and AstraZeneca to m...
Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19 vaccineThe Phase-II study of the vaccine, ZyCoV-D, had been conducted in over 1,000 healthy adult volunteers as part of the adaptive Phase-I and I...
Gujarat: PM Modi reviews vaccine development at Zydus Cadila facilityAfter his arrival at Ahmedabad airport from Delhi shortly after 9 am, Modi flew to the Zydus Cadila plant and held discussions with the pro...
Oxford candidate the first Covid vaccine likely to be available in India by end of yearIt is believed that the two local candidates — which are in early stages of human trials — will enter the market with a lag of a few weeks ...